Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Heuck, Christoph J
85  Ergebnisse:
Personensuche X
?
1

Long-Term Efficacy and Safety Results From the Phase 1/2 Mo..:

Rasche, Leo ; Schinke, Carolina ; Touzeau, Cyrille...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S240 , 2024
Link: https://doi.org/10.1016/..
 
?
2

GPRC5D as a novel target for the treatment of multiple myel..:

Rodriguez-Otero, Paula ; van de Donk, Niels W. C. J. ; Pillarisetti, Kodandaram...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Clinical Management of Patients With Relapsed/Refractory Mu..:

Chari, Ajai ; Krishnan, Amrita ; Rasche, Leo...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  10 - p. 665-693.e14 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Correction: GPRC5D as a novel target for the treatment of m..:

Rodriguez-Otero, Paula ; van de Donk, Niels W. C. J. ; Pillarisetti, Kodandaram...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
5

Matching-adjusted indirect comparison of talquetamab vs sel..:

Reece, Donna ; Diels, Joris ; Van Sanden, Suzy...
Current Medical Research and Opinion.  , 2024
Link: https://doi.org/10.1080/..
 
?
6

MM-492 Long-term Efficacy and Safety Results From the Phase..:

Rasche, Leo ; Schinke, Carolina ; Touzeau, Cyrille...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S561-S562 , 2024
Link: https://doi.org/10.1016/..
 
?
7

EVIDENCE meta-analysis: evaluating minimal residual disease..:

Landgren, Ola ; Prior, Thomas J. ; Masterson, Tara...
Blood.  144 (2024)  4 - p. 359-367 , 2024
Link: https://doi.org/10.1182/..
 
?
8

Evaluation of Drug–Drug Interaction Potential of Talquetama..:

Willemin, Marie-Emilie ; Gong, Jue ; Hilder, Brandi W....
Targeted Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
9

POSTER: MM-191 Analysis of Infections and Parameters of Hum..:

Rodriguez-Otero, Paula ; Schinke, Carolina ; Chari, Ajai...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S225 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMU..:

Rasche, Leo ; Schinke, Carolina ; Chari, Ajai...
HemaSphere.  7 (2023)  S3 - p. e646904e , 2023
Link: https://doi.org/10.1097/..
 
?
11

P-045 Early treatment with bispecific T-cell redirectors (t..:

Rodriguez-Otero, Paula ; Mateos, Maria-Victoria ; Palacios, Juan José Lahuerta...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S59-S60 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB V..:

Chari, Ajai ; Diels, Joris ; Van Sanden, Suzy...
HemaSphere.  7 (2023)  S3 - p. e81043cc , 2023
Link: https://doi.org/10.1097/..
 
?
13

S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (..:

Touzeau, Cyrille ; Schinke, Carolina ; Minnema, Monique...
HemaSphere.  7 (2023)  S3 - p. e5955094 , 2023
Link: https://doi.org/10.1097/..
 
?
14

P-023 Talquetamab, a G protein–coupled receptor family C gr..:

Krishnan, Amrita ; Costa, Luciano ; Schinke, Carolina...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S45-S46 , 2023
Link: https://doi.org/10.1016/..
 
?
15

MM-191 Analysis of Infections and Parameters of Humoral Imm..:

Rodriguez-Otero, Paula ; Schinke, Carolina ; Chari, Ajai...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S480 , 2023
Link: https://doi.org/10.1016/..
 
1-15